Dalkhimpharm conducts large-scale modernization

| By | Dalkhimpharm, Drug Manufacturing, Import Substitution

A large-scale modernization aimed at expanding production facilities and manufacturing competitive products has began at Dalkhimpharm plant.

This year alone, the company spent more than thirty million rubles to purchase modern equipment. This is a town-forming enterprise and, according to the acting Mayor of Khabarovsk Sergey Kravchuk, the company will receive help in finding new partners for economic cooperation. Today, the plant produces sixty drugs under the import substitution program.

dalkhimfarm 2

“We expand the output of our products and, at the same time, start manufacturing of new drugs. Last year, it was mezaton and, this year, it is pentoxifylline and sodium thiosulfate,” said Irina Guseva, Executive Director of Dalkhimpharm JSC.


To expand the output of medicinal products, the company purchased a packaging line and equipment to manufacture large ampoules for magnesium sulphate, novocaine, and sodium thiosulfate. Today, the plant ships medicines to the Western regions of Russia and also works with foreign partners.

SOURCE: news.khabara.ru
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.